Atea Pharmaceuticals director Bruce Polsky reports sale of $168,094.9506 in common shares
AVIR•Director Bruce Polsky sold 41,226 Atea Pharmaceuticals common shares from November 16 to 18, 2026, and exercised options for 75,000 shares at $1.24 each. He held 158,580 shares directly after the transactions.
1. Share transactions
Bruce Polsky sold 41,226 common shares during November 16–18, 2026, at prices of $4.2683, $4.0316 and $3.9502 on the respective days. During the same period, he exercised options for 75,000 common shares at $1.24 per share. His direct holdings totaled 158,580 shares after the transactions.




